Varenicline Tartrate

Modify Date: 2024-01-02 18:18:16

Varenicline Tartrate Structure
Varenicline Tartrate structure
 Common Name Varenicline Tartrate
CAS Number 375815-87-5 Molecular Weight 361.35
Density N/A Boiling Point 400.6ºC at 760 mmHg
Molecular Formula C17H19N3O6 Melting Point 206-208ºC
MSDS Chinese USA Flash Point 48.2 °F
Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08		 Signal Word Danger

 Use of Varenicline Tartrate


Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.IC50 value:Target: α4β2 nAChRVarenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking.

 Names

Name varenicline tartrate
Synonym More Synonyms

 Varenicline Tartrate Biological Activity

Description Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.IC50 value:Target: α4β2 nAChRVarenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking.
Related Catalog
References

[1]. Krebs P, Sherman SE. Review: Varenicline for tobacco cessation does not increase CV serious adverse events. Ann Intern Med. 2012 Aug 21;157(4):JC2-2.

[2]. Kikkawa, H.; Maruyama, N.; Fujimoto, Y.; Hasunuma, T. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. Journal of Clinical Pharmacology (2011), 51(4), 527-537.

[3]. Pachas GN, Cather C, Pratt SA et al. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn. 2012;8(2):117-125.

[4]. Bordia T, Hrachova M, Chin M et al. Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum. J Pharmacol Exp Ther. 2012 Aug;342(2):327-34.

[5]. Varenicline

 Chemical & Physical Properties

Boiling Point 400.6ºC at 760 mmHg
Melting Point 206-208ºC
Molecular Formula C17H19N3O6
Molecular Weight 361.35
PSA 23.79000
LogP 4.49528
Storage condition Desiccate at RT
Water Solubility DMSO: >5mg/mL

 Safety Information

Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger
Hazard Statements H225-H301 + H311 + H331-H370
Precautionary Statements P210-P260-P280-P301 + P310-P311
Hazard Codes Xn,N,T,F
Risk Phrases 22-50-39/23/24/25-23/24/25-11
Safety Phrases 22-57-45-36/37-16-7
RIDADR UN 3077 9 / PGIII
Flash Point(F) 48.2 °F
Flash Point(C) 9 °C

 Synthetic Route

Varenicline structure

Varenicline

CAS#:249296-44-4
Tartaric acid structure

Tartaric acid

CAS#:87-69-4

~64%

Varenicline Tartrate Structure

Varenicline Tartrate

CAS#:375815-87-5
Literature: Medichem, S.A. Patent: US2012/4239 A1, 2012 ; Location in patent: Page/Page column 12 ;

 Precursor & DownStream

Precursor  2

DownStream  0

 Articles14

More Articles
Concurrent access to nicotine and sucrose in rats.

Psychopharmacol. Ser. 232(8) , 1451-60, (2015)

Animal models that allow concurrent access to drug and nondrug reinforcers provide unique insight into the etiology, maintenance, and treatment of drug use.We sought to develop and utilize a concurren...
Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Neuropharmacology 99 , 142-55, (2015)

Chronic treatment with nicotine is known to increase the α4β2-nAChR sites in brain, to decrease α6β2-nAChR sites and to have minimal effect on α3β4-and α7-nAChR populations. Varenicline is now used as...
Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.

Alcohol. Clin. Exp. Res. 38(12) , 3033-42, (2015)

Varenicline, a partial nicotinic acetylcholine receptor (nAChR) agonist, is a promising new drug for the treatment of alcohol (ethanol [EtOH]) dependence. Varenicline has been approved by the Food and...

 Synonyms

7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrate Champix
(2R,3R)-3-carboxy-2,3-dihydroxypropanoate de (1R,12S)-5,8-diaza-14-azoniatétracyclo[10.3.1.0.0]hexadéca-2(11),3,5,7,9-pentaène
Chantix
(1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaene (2R,3R)-3-carboxy-2,3-dihydroxypropanoate
(1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaen-(2R,3R)-3-carboxy-2,3-dihydroxypropanoat
Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (6R,10S)-7,8,9,10-tetrahydro-6,10-methano-6H-azepino[4,5-g]quinoxaline (1:1)
Champix
Varenicline tartrate
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Varenicline Tartrate suppliers

Price: $84/5mg

Reference only. check more Varenicline Tartrate price

Related Compounds: More...
Varenicline-d4
2183239-01-0
Varenicline
249296-44-4
Varenicline Lactam
873302-30-8
varenicline succinate
535959-68-3
Varenicline Carbamoyl β-D-Glucuronide
535920-98-0
Varenicline (Hydrochloride)
230615-23-3
varenicline citrate
536696-70-5
ethylenediamine tartrate
22719-15-9
(R,R)-3-amino-α[[[2-(4-methoxyphenyl)-1-methylethyl](phenylmethyl)amino]methyl]-4-(phenylmethoxy)-benzenemethanol
245759-62-0
Chemsrc provides Varenicline Tartrate(CAS#:375815-87-5) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Varenicline Tartrate are included as well.>> amp version: Varenicline Tartrate

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved